CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
Take the Rare Disease Day Quiz!
Test your knowledge about rare diseases, which affect more people than you think.
What to Tell the Kids About COVID-19?
A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.
Unique in many ways
CSL Behring is one of the best employers in Switzerland. A glimpse behind the scenes.
What is a Phase III clinical trial?
A potential hyperimmune treatment for COVID-19 reaches a regulatory milestone in testing its efficacy and safety.
First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine
As co-leader, CSL Behring is very actively involved in this project. The product for the clinical trial phase 3 was manufactu…